4.4 Article

High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Molecular subgroups of medulloblastoma: the current consensus

Michael D. Taylor et al.

ACTA NEUROPATHOLOGICA (2012)

Article Pathology

Claudin-6 is a Nonspecific Marker for Malignant Rhabdoid and Other Pediatric Tumors

Lisa M. Sullivan et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)

Article Medicine, Research & Experimental

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

Ryan S. Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Multidisciplinary Sciences

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Jeremy Schwartzentruber et al.

NATURE (2012)

Review Clinical Neurology

Molecular diagnostics of CNS embryonal tumors

Stefan M. Pfister et al.

ACTA NEUROPATHOLOGICA (2010)

Article Genetics & Heredity

Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome

Reinhard Schneppenheim et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2010)

Article Clinical Neurology

Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors

Diane K. Birks et al.

BRAIN PATHOLOGY (2010)

Article Multidisciplinary Sciences

A map of human genome variation from population-scale sequencing

David Altshuler et al.

NATURE (2010)

Review Oncology

The role of SMARCB1/INI1 in development of rhabdoid tumor

Charles W. M. Roberts et al.

CANCER BIOLOGY & THERAPY (2009)

Article Pathology

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

AR Judkins et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)